GERN 240830 4.50C (GERN240830C4500) Stock Options, News & Quotes

0.15
-0.07-31.82%

15min DelayClose Aug 30 16:00 ET

0.20High0.08Low

SymbolStock Name

Latest PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry

WatchlistPaper Trade

Comments

Trytosaveabit

Jul 26 06:42

Hmm

$Geron (GERN.US)$ Geron Announces Updated Nccn Guidelines® Recommending Rytelo™ (Imetelstat) for the Treatment of Symptomatic Anemia in Patients With Lower-Risk Mds

103136267

Jun 18 08:39

$Geron (GERN.US)$ Great stock at a great price, time to buy!
折扣价赶快买！

Stock Region

Jun 11 14:25

Investment Bank Initiates Overweight Rating For Biotech Firm

Barclays Initiates Coverage On Geron Corporation with Overweight Rating, Announces Price Target of $9.
On June 2, 2024, Barclays initiated coverage of Geron Corporation (NasdaqGS:GERN) with an Overweight rating, setting a price target of $9. At the time of this announcement, Geron’s stock was trading at $4.83, indicating a bullish sentiment from Barclays and predicting significant potential upside for investors. $Geron (GERN.US)$
https://stockregion.app/p/investment-bank-initiates-overweight

Meltyy

Jun 11 03:48

🔔 FDA PDUFA Update…

🚨 1 AdCom & 3 PDUFA decisions this week:
$Genfit (GNFT.US)$ & $IPSEN SA SPONS ADR EA REPR 0.25 ORD (IPSEY.US)$ : 🤔
⇨ Elafibranor
‣ Primary biliary cholangitis
‣ PDUFA date: 6/10/24
$Regeneron Pharmaceuticals (REGN.US)$ : 🤔
⇨ Kevzara (sarilumab)
‣ Polyarticular juvenile idiopathic arthritis
‣ PDUFA date: 6/10/24
$Bristol-Myers Squibb (BMY.US)$ : 🤔
⇨ Augtyro™ (Repotrectinib)
‣ PDUFA date: 6/15/24 (sNDA)
🗓️ Last week’s PDUFAs:
$GlaxoSmithKline (GSK.US)$ : Approved 6/7 🎉
⇨ Arexvy
‣ Respiratory s...

IDKWTFIMDOING

Jun 10 21:17

$Geron (GERN.US)$
This could get interesting considering the short stats.
2.85 days to cover. 10.46% short floats.